睿昂基因
(688217)
| 流通市值：15.16亿 | | | 总市值：15.16亿 |
| 流通股本：5585.59万 | | | 总股本：5585.59万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 139,103,619.1 | 104,748,350.73 | 54,738,007.28 | 242,306,170.99 |
| 营业收入 | 139,103,619.1 | 104,748,350.73 | 54,738,007.28 | 242,306,170.99 |
| 二、营业总成本 | 153,715,390.64 | 108,964,865.38 | 55,633,595.22 | 250,955,636.13 |
| 营业成本 | 36,927,288.05 | 28,300,271.23 | 15,872,484.58 | 61,719,324.93 |
| 税金及附加 | 2,536,509.12 | 1,605,985.95 | 744,348.76 | 2,281,058.53 |
| 销售费用 | 36,259,341.83 | 24,357,765.26 | 13,062,526.52 | 72,899,960.24 |
| 管理费用 | 36,752,893.62 | 23,999,212.16 | 14,777,043.39 | 54,422,369.06 |
| 研发费用 | 42,449,127.26 | 31,647,198.23 | 10,988,068.94 | 62,470,671.03 |
| 财务费用 | -1,209,769.24 | -945,567.45 | 189,123.03 | -2,837,747.66 |
| 其中:利息费用 | - | 152,641.12 | - | 884,673.47 |
| 其中:利息收入 | - | 1,276,933.19 | - | 3,171,198.17 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -47,298.98 | -479,941.91 | 54,991.97 | 872,958.26 |
| 加:投资收益 | 1,709,855.46 | 1,560,616.96 | 495,024 | 1,618,455.25 |
| 资产处置收益 | 47,904.94 | 47,904.93 | 62,237.97 | 119,222.25 |
| 资产减值损失(新) | -355,913.78 | -258,053.3 | -120,852.61 | -17,771,809.12 |
| 信用减值损失(新) | -7,222,974.28 | -4,076,766.06 | 115,963.27 | -6,841,777.83 |
| 其他收益 | 4,484,070.5 | 4,117,341.2 | 2,085,239.6 | 2,230,560.15 |
| 四、营业利润 | -15,996,127.68 | -3,305,412.83 | 1,797,016.26 | -28,421,856.18 |
| 加:营业外收入 | 8,582.22 | 3,967.86 | 76.18 | 241,571.49 |
| 减:营业外支出 | 525,314.13 | 51,056.09 | 15,850.01 | 294,250.75 |
| 五、利润总额 | -16,512,859.59 | -3,352,501.06 | 1,781,242.43 | -28,474,535.44 |
| 减:所得税费用 | -4,203,906.71 | -2,232,245.06 | -60,186.88 | -2,567,809.34 |
| 六、净利润 | -12,308,952.88 | -1,120,256 | 1,841,429.31 | -25,906,726.1 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -12,308,952.88 | -1,120,256 | 1,841,429.31 | -25,906,726.1 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -5,620,662.24 | 3,554,296.98 | 3,355,013.27 | -15,764,502.19 |
| 少数股东损益 | -6,688,290.64 | -4,674,552.98 | -1,513,583.96 | -10,142,223.91 |
| 扣除非经常损益后的净利润 | -12,197,962.85 | -2,827,428.63 | -687,896.05 | -19,247,569.96 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.1 | 0.06 | 0.06 | -0.28 |
| (二)稀释每股收益 | -0.1 | 0.06 | 0.06 | -0.28 |
| 九、综合收益总额 | -12,308,952.88 | -1,120,256 | 1,841,429.31 | -25,906,726.1 |
| 归属于母公司股东的综合收益总额 | -5,620,662.24 | 3,554,296.98 | 3,355,013.27 | -15,764,502.19 |
| 归属于少数股东的综合收益总额 | -6,688,290.64 | -4,674,552.98 | -1,513,583.96 | -10,142,223.91 |
| 公告日期 | 2025-10-29 | 2025-08-29 | 2025-04-25 | 2025-04-18 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |